SCHEMBL9566593

SCHEMBL9566593

Nc1nc(N)nc(-c2cc(Br)ccc2Cl)n1

nearest known ligand 0.68

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 1/20 0.68
PDE4D Q08499 1/20 0.68
NPC1 O15118 4/20 0.50
RAB9A P51151 2/20 0.50
MAPT P10636 1/20 0.47
XBP1 P17861 1/20 0.47
HIF1A Q16665 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.44
HTT P42858 2/20 0.44
AGPAT2 O15120 4/20 0.43
HSP90AA1 P07900 2/20 0.41
HSP90AB1 P08238 1/20 0.39
PABPC1 P11940 1/20 0.38
HRH4 Q9H3N8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9566626 0.85 HTR2B (0.50) HTR2BPDE4DNPC1RAB9AMAPT
SCHEMBL9566542 0.81 HTR2B (0.72) HTR2BPDE4DNPC1RAB9AMAPT
Irsogladine SCHEMBL29517870 0.81 HTR2B (1.00) HTR2BPDE4DNPC1RAB9ASMN1; SMN2
SCHEMBL16179144 0.81 GPR35 (0.54) HTR2BPDE4DNPC1RAB9AMAPT
Irsogladine SCHEMBL62215 0.81 HTR2B (1.00) HTR2BPDE4DNPC1RAB9ASMN1; SMN2
SCHEMBL9566518 0.81 NPC1 (0.47) HTR2BPDE4DNPC1RAB9AMAPT
SCHEMBL4369095 0.80 AGPAT2 (0.68) HTR2BPDE4DNPC1RAB9AMAPT
SCHEMBL2622394 0.78 AGPAT2 (0.65) HTR2BPDE4DNPC1RAB9AMAPT
SCHEMBL9566562 0.78 HTR2B (0.68) HTR2BPDE4DNPC1RAB9ASMN1; SMN2
SCHEMBL9566522 0.78 HTR2B (0.68) HTR2BPDE4DNPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0563386-A1 ANTICANCER COMPOSITION AND COMPOUND NIPPON SHINYAKU COMPANY, LIMITED (JP) 1993-10-06 EP disclosed